Purification, characterization and immunogenicity of recombinant varicella-zoster virus glycoprotein gE secreted by Chinese hamster ovary cells

Virus Research

Volumn 40, Issue 2, 1996, Pages 199-204

  Haumont, Michele ^a   Jacquet, Alain ^a   Massaer, Marc ^a   Deleersnyder, Virginie ^a   Mazzu, Pasqualina ^a   Bollen, Alex ^a   Jacobs, Paul ^a  

^a FREE UNIVERSITY OF BRUSSELS   (Belgium)

Author keywords

gE glycoprotein; Recombinant antigen; Virus; VZV

Indexed keywords

RECOMBINANT PROTEIN; VARICELLA ZOSTER VACCINE; VIRUS ANTIGEN; VIRUS GLYCOPROTEIN;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; HAMSTER; IMMUNOGENICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN PURIFICATION; VARICELLA ZOSTER VIRUS;

AMIDOHYDROLASES; ANIMALS; ANTIBODIES, VIRAL; CHO CELLS; CRICETINAE; HERPESVIRUS 3, HUMAN; LECTINS; MICE; MICE, INBRED BALB C; PEPTIDE-N4-(N-ACETYL-BETA-GLUCOSAMINYL) ASPARAGINE AMIDASE; PROTEIN PROCESSING, POST-TRANSLATIONAL; RECOMBINANT FUSION PROTEINS; VIRAL ENVELOPE PROTEINS;

ANIMALIA; CRICETINAE; CRICETULUS GRISEUS; HUMAN HERPESVIRUS 3; MAMMALIA;

EID: 0029964068     PISSN: 01681702     EISSN: None     Source Type: Journal    
DOI: 10.1016/0168-1702(95)01270-2     Document Type: Article

References (23)

1. Arvin, A.M., Kinney-Thomas, E., Shriver, K., Grose, C., Koropchac, C., Scranton, E., Witek, A.E. and Diaz, P.S. (1986) Immunity to varicella-zoster viral glycoproteins, gpI (gp 90/58) and gpIII (gp 118), and to a nonglycosylated protein, p 170. J. Immunol. 137, 1346-1351.
2. Arvin, A.M., Sharp, M., Smith, S., Koropchac, C.M., Diaz, P.S., Kinchington, P., Ruyechan, W. and Hay, J. (1991) Equivalent recognition of a varicella-zoster virus immediate early protein (Ie62) and glycoprotein I by cytotoxic T lymphocytes of either CD4 or CD8 phenotype. J. Immunol. 146, 257-264.
3. Brunell, P.A., Novelli, V.M., Keller, P.M. and Ellis, R.W., (1987) Antibodies to the three major glycoproteins of varicella-zoster virus: search for the relevant host immune response. J. Infect. Dis. 156, 430-435.
4. Cockett, M.I., Bebbington, C.R. and Yarranton, G.T. (1990) High level expression of tissue inhibitor of metalloproteinases in Chinese hamster ovary cells using glutamine synthetase gene amplification. Biotechnology 8, 662-667.
5. Davison, A.J. (1983) DNA sequence of the Us component of the varicella zoster virus genome. EMBO J. 2, 2203-2209.
6. Davison, A.J. and Scott, J.E. (1986) The complete DNA sequence of varicella-zoster virus. J. Gen. Virol. 67, 1759-1816.
7. Diaz, P.S., Smith, S., Hunter, E. and Arvin, A.M. (1988) Immunity to whole varicella-zoster virus antigen and glycoproteins I and p170: relation to the immunizing regimen of live attenuated varicella vaccine. J. Infect. Dis. 158, 1245-1252.
8. Dubey, L., Steinberg, S.P., La Russa, P., Oh, P. and Gershon, A. (1988) Western blot analysis of antibody to varicella-zoster virus. J. Infect. Dis. 157, 882-888.
9. Forghani, B., Dupuis, K.W. and Schmidt, N.J. (1990) Epitopes functional in neutralization of Varicella-zoster virus. J. Clin. Microbiol. 28, 2500-2506.
10. Grose, C. (1989) Congenital varicella-zoster virus infection and the failure to establish virus-specific cell-mediated immunity. Mol. Biol. Med. 6, 453-462.
11. Grose, C. and Litwin, V. (1988) Immunology of the varicella-zoster virus. J. Infect. Dis. 157, 817-881.
12. Jacquet, A., Massaer, M., Haumont, M., Houard, S., Deleersnyder, V., Place, M., Bollen, A. and Jacobs, P. (1995) Purification and characterization of recombinant varicella-zoster virus glycoprotein anchor-less gpII, secreted by Chinese hamster ovary cells. Protein Expression and Purification 6, 91-98.
13. Keller, P.M., Neff, B.J. and Ellis, R.W. (1984) Three major glycoprotein genes of varicella-zoster virus whose products have neutralization epitopes. J. Virol. 52, 293-297.
14. Litwin, V., Jackson, W. and Grose, C. (1992) Receptor properties of two varicella-zoster virus glycoproteins, gpI and gpIV, homologous to herpes simplex virus gE and gI. J. Virol. 66, 3643-3651.
15. Ludvikova, V., Kunke, D., Hamsikova, E., Kutinova, L. and Vonka, V. (1991) Immunogenicity in mice of varicella-zoster virus glycoprotein I expressed by a vaccinia virus-varicella-zoster virus recombinant. J. Gen. Virol. 72, 1445-1449.
16. Massaer, M., Haumont, M., Place, M., Bollen, A. and Jacobs, P. (1993) Induction of neutralizing antibodies by varicella-zoster virus gpII glycoprotein expressed from recombinant vaccinia virus. J. Gen. Virol. 74, 491-494.
17. Matsui, S., Okuno, T. and Shiraki, K. (1994) Functional roles of terminal glycomoieties in Varicella-zoster virus infection. Virology 198, 50-58.
18. Montalvo, E.A. and Grose, C. (1986) Varicella zoster virus glycoprotein gpI is selectively phosphorylated by a virus-induced protein kinase. Proc. Natl. Acad. Sci. U.S.A. 83, 8967-8971.
19. Plotkin, S.A. (1994) Vaccines for varicella-zoster virus and cytomegalovirus: recent progress. Science 265, 1383-1385.
20. Soike, K.F., Keller, P.M. and Ellis, R.W. (1987) Immunization of monkeys with varicella-zoster virus glycoprotein antigens and their response to challenge with simian varicella virus. J. Med. Virol. 21, 307-313.
21. Vafai, A., Jensen, K. and Kubo, R. (1989) Existence of similar antigenic sites on varicella-zoster virus gpI and gpIV. Virus Res. 13, 319-336.
22. Vafai, A. (1994) Antibody-binding sites on truncated forms of varicella-zoster virus gpI(gE) glycoprotein. Vaccine 12, 1265-1269.
23. Yao, Z., Jackson, W., Forghani, B. and Grose, C. (1993) Varicella-zoster virus glycoprotein gpI/gpIV receptor: Expression, complex formation, and antigenicity within the vaccinia virus-T7 RNA polymerase transfection system. J. Virol. 67, 305-314.